Saikosaponin A (SSA) and saikosaponin C (SSC) ameliorated AD-like skin lesions by reducing TSLP expression [13]; however, the impact of SSA on FLG expression in inflamed skin remains unclear. The gene discussed is TSLP; the disease is Alzheimer disease.